Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1997 Dec;77(6):488–492. doi: 10.1136/adc.77.6.488

Antibody persistence and Haemophilus influenzae type b carriage after infant immunisation with PRP-T

P Heath 1, J Bowen-Morris 1, D Griffiths 1, H Griffiths 1, D Crook 1, E Moxon 1
PMCID: PMC1717421  PMID: 9496180

Abstract





OB JECTIVES—To assess the persistence of serum Haemophilus influenzae type b antibodies and the prevalence of H influenzae type b carriage in a group of preschool age children previously vaccinated in infancy.
DESIGN—Names were randomly selected from immunisation records. Families were visited on five occasions over a period of 12 months and throat swabs were taken from all family members present, with blood obtained from children at the first and last visits.
RESULTS—One hundred and fifty three children at a median age of 3.6 years had a geometric mean titre (GMT) of 1.06 µg/ml (95% CI 0.80to 1.38). Eight per cent had an undetectable antibody concentration, received a booster dose of plain PRP vaccine, and responded with concentrations > 2 µg/ml. GMT at 4.5 years of age was 0.89 µg/ml (0.69 to 1.16). Twelve children who had been exposed to H influenzae had a GMT of 4.7 v 0.8 µg/ml for those without exposure.
CONCLUSIONS—Accelerated immunisation against H influenzae without a second year booster results in persistence of satisfactory serum concentrations of antibody to 4.5 years of age. In those with undetectable antibody, immunological memory may still be present.



Full Text

The Full Text of this article is available as a PDF (98.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barbour M. L., Booy R., Crook D. W., Griffiths H., Chapel H. M., Moxon E. R., Mayon-White D. Haemophilus influenzae type b carriage and immunity four years after receiving the Haemophilus influenzae oligosaccharide-CRM197 (HbOC) conjugate vaccine. Pediatr Infect Dis J. 1993 Jun;12(6):478–484. doi: 10.1097/00006454-199306000-00005. [DOI] [PubMed] [Google Scholar]
  2. Barbour M. L., Mayon-White R. T., Coles C., Crook D. W., Moxon E. R. The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. J Infect Dis. 1995 Jan;171(1):93–98. doi: 10.1093/infdis/171.1.93. [DOI] [PubMed] [Google Scholar]
  3. Booy R., Heath P. T., Slack M. P., Begg N., Moxon E. R. Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster. Lancet. 1997 Apr 26;349(9060):1197–1202. doi: 10.1016/s0140-6736(96)06392-1. [DOI] [PubMed] [Google Scholar]
  4. Booy R., Hodgson S. A., Slack M. P., Anderson E. C., Mayon-White R. T., Moxon E. R. Invasive Haemophilus influenzae type b disease in the Oxford region (1985-91). Arch Dis Child. 1993 Aug;69(2):225–228. doi: 10.1136/adc.69.2.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Booy R., Hodgson S., Griffiths H., Chapel H. M., Moxon E. R. Antibody persistence after accelerated immunisation against Haemophilus influenzae type b. BMJ. 1993 Apr 10;306(6883):971–972. doi: 10.1136/bmj.306.6883.971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Booy R., Taylor S. A., Dobson S. R., Isaacs D., Sleight G., Aitken S., Griffiths H., Chapel H., Mayon-White R. T., Macfarlane J. A. Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule. Arch Dis Child. 1992 Apr;67(4):475–478. doi: 10.1136/adc.67.4.475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Claesson B. A., Trollfors B., Anderson P. W., Johansson J., Taranger J., Schneerson R., Robbins J. B. Serum antibodies in six-year-old children vaccinated in infancy with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine. Pediatr Infect Dis J. 1996 Feb;15(2):170–172. doi: 10.1097/00006454-199602000-00016. [DOI] [PubMed] [Google Scholar]
  8. Falla T. J., Crook D. W., Brophy L. N., Maskell D., Kroll J. S., Moxon E. R. PCR for capsular typing of Haemophilus influenzae. J Clin Microbiol. 1994 Oct;32(10):2382–2386. doi: 10.1128/jcm.32.10.2382-2386.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Käyhty H., Peltola H., Karanko V., Mäkelä P. H. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis. 1983 Jun;147(6):1100–1100. doi: 10.1093/infdis/147.6.1100. [DOI] [PubMed] [Google Scholar]
  10. Mohle-Boetani J. C., Ajello G., Breneman E., Deaver K. A., Harvey C., Plikaytis B. D., Farley M. M., Stephens D. S., Wenger J. D. Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines. Pediatr Infect Dis J. 1993 Jul;12(7):589–593. doi: 10.1097/00006454-199307000-00009. [DOI] [PubMed] [Google Scholar]
  11. Mäkelä P. H., Peltola H., Käyhty H., Jousimies H., Pettay O., Ruoslahti E., Sivonen A., Renkonen O. V. Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland. J Infect Dis. 1977 Aug;136 (Suppl):S43–S50. doi: 10.1093/infdis/136.supplement.s43. [DOI] [PubMed] [Google Scholar]
  12. Robbins J. B., Parke J. C., Jr, Schneerson R., Whisnant J. K. Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies. Pediatr Res. 1973 Mar;7(3):103–110. doi: 10.1203/00006450-197303000-00001. [DOI] [PubMed] [Google Scholar]
  13. Robbins J. B., Schneerson R., Glode M. P., Vann W., Schiffer M. S., Liu T. Y., Parke J. C., Jr, Huntley C. Cross-reactive antigens and immunity to diseases caused by encapsulated bacteria. J Allergy Clin Immunol. 1975 Aug;56(2):141–151. doi: 10.1016/0091-6749(75)90119-0. [DOI] [PubMed] [Google Scholar]
  14. Santosham M., Wolff M., Reid R., Hohenboken M., Bateman M., Goepp J., Cortese M., Sack D., Hill J., Newcomer W. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex. N Engl J Med. 1991 Jun 20;324(25):1767–1772. doi: 10.1056/NEJM199106203242503. [DOI] [PubMed] [Google Scholar]
  15. Takala A. K., Eskola J., Leinonen M., Käyhty H., Nissinen A., Pekkanen E., Mäkelä P. H. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J Infect Dis. 1991 Nov;164(5):982–986. doi: 10.1093/infdis/164.5.982. [DOI] [PubMed] [Google Scholar]
  16. Weinberg G. A., Einhorn M. S., Lenoir A. A., Granoff P. D., Granoff D. M. Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine. J Pediatr. 1987 Jul;111(1):22–27. doi: 10.1016/s0022-3476(87)80336-0. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES